tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Leap Therapeutics reports updated results from Phase B of DeFianCe study
PremiumThe FlyLeap Therapeutics reports updated results from Phase B of DeFianCe study
3M ago
Leap Therapeutics Reports Increased Q1 Losses
Premium
Company Announcements
Leap Therapeutics Reports Increased Q1 Losses
4M ago
Leap Therapeutics Reports Positive Clinical Data and Financial Results
Premium
Company Announcements
Leap Therapeutics Reports Positive Clinical Data and Financial Results
6M ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
8M ago
Apple downgraded, Rivian initiated: Wall Street’s top analyst calls
Premium
The Fly
Apple downgraded, Rivian initiated: Wall Street’s top analyst calls
8M ago
Leap Therapeutics price target lowered to $3 from $15 at Piper Sandler
Premium
The Fly
Leap Therapeutics price target lowered to $3 from $15 at Piper Sandler
8M ago
Leap Therapeutics reports Q3 EPS (44c), consensus (48c)
PremiumThe FlyLeap Therapeutics reports Q3 EPS (44c), consensus (48c)
11M ago
Leap Therapeutics (LPTX) Q3 Earnings Cheat Sheet
Premium
Pre-Earnings
Leap Therapeutics (LPTX) Q3 Earnings Cheat Sheet
11M ago
Leap Therapeutics completes enrollment in Part B of DeFianCe study
Premium
The Fly
Leap Therapeutics completes enrollment in Part B of DeFianCe study
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100